Fibrocell Science, Inc.
Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | |
|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $355,000 | $492,000 | $180,000 | $200,000 |
| Operating income | −$12.4M | −$19.0M | −$26.5M | −$37.4M | −$30.0M | −$30.5M |
| Net income | −$10.3M | −$16.2M | −$15.3M | −$34.5M | −$14.0M | −$30.6M |
| Total assets | $15.8M | $19.4M | $19.6M | $36.7M | $45.6M | $69.0M |
| Total liabilities | $6.2M | $10.4M | $11.7M | $22.5M | $15.2M | $4.3M |
| Equity | $9.6M | $9.0M | $7.9M | $14.2M | $30.4M | $64.7M |
| EPS (diluted) | $-1.45 | $-6.67 | $-1.18 | $-0.85 | $-0.35 | $-1.12 |
| Shares out. | 28.4M | 44.1M | 43.9M | 40.9M | 40.8M | 655.7M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2018- Operating margin
- —
- Net margin
- —
- Return on equity
- −107.5%
- Return on assets
- −65.2%
- Return on capital (ROCE)
- −91.2%
- Liabilities / assets
- 39.4%
- Debt / equity
- 0.65×
- Book value / share
- $0.34
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2018- Altman Z″ (distress)
- -37.64distress
- Accruals / assets
- 15.5%high accruals
- Piotroski F-Score
- 4/8mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 2 severe● 2 warning● 1 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Negative operating cash flow
- High accruals — earnings-quality risk
- Conservative leverage (liabilities < 50% of assets)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗May 12, 2014
- NT 10-Qmissed a reporting deadline ↗Nov 13, 2009
- NT 10-Kmissed a reporting deadline ↗Mar 31, 2009
- NT 10-Kmissed a reporting deadline ↗Mar 19, 2007
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Material events
SEC Form 8-K · most recent- Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylawsDec 13, 2019
- Shareholder voteDec 10, 2019
- Other material eventNov 22, 2019
- Entered a material agreement · Terminated a material agreement · Other material eventSep 13, 2019
- Other material eventSep 12, 2019
- Director / officer changeAug 22, 2019
- Results of operations · Other material eventAug 15, 2019
- Other material eventJul 2, 2019
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (2)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.